Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene ...

Tightening of U.S. regulation and capital is leading Chinese biotechs to alternative and new models of financing, ranging from cross-border licensing deals, M&As, the so-called newco model and ...

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...

The global marketplace is here to stay. But global competition must take place on fair, transparent and enforceable terms, ...

As first quarter earnings begin, executives are confronting market turmoil, regulatory instability and the threat of U.S.

These businesses operate similarly to pharmaceutical companies. However, the key differential in biotechnology is the approach to developing new treatments. Traditional pharmaceuticals use ...

i.e., biotech applications in the medical and pharmaceutical industries, Palermo focuses on blue – marine – biotechnology, while Opole is strong in environmental biotechnology. "Biotechnology ...

Its key asset is the Captisol platform, which over 100 biotech and pharma companies have licensed. Ligand Pharmaceuticals reported fourth-quarter adjusted EPS of $1.27, beating the consensus of $1 ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Jonathan has worked closely with leading pharmaceutical, biotech, and healthcare organizations such as Pfizer, Becton Dickinson, Illumina, Abbott Vascular, the University of California ...

America must invest at least $15 billion over the next five years to support its domestic biotechnology sector if it doesn’t want to lose to China, warns a national security commission made up ...